Nasdaq-Listed Companies

Behind the Bell: Genmab

Published

About this Series

Behind the Bell

Behind the Bell is an interview series featuring CEOs, executives or founders, live from MarketSite on a company’s listing day or milestone celebration—generally in the moments after ringing the opening or closing bell.

In this episode of Behind the Bell, Genmab President & CEO Jan van de Winkel reflects on 25 years of Genmab. Genmab is an international biotechnology company creating innovative and differentiated antibody therapeutics to improve the lives of patients.

More in this Series

See all

Nasdaq Watch

See what's playing at Nasdaq

Watch Now